The Supreme Court meant what it said in China Agritech, Inc. v. Resh – that is the primary lesson from the First Circuit’s January 30 th decision in In re Celexa and Lexapro Marketing and Sales ...

Employees of Forest Labs and that company's rivals should read the U.S. government's complaint against the company, which alleges off-label promotion of Lexapro and Celexa for use in children. The ...

NEW YORK, March 20 (Reuters) - Just weeks after prosecutors accused Forest Laboratories Inc of illegally marketing its anti-depressants Celexa and Lexapro to children and paying pediatricians ...

ST. LOUIS (CN) – Forest Pharmaceuticals and Forest Laboratories illegally marketed two antidepressant drugs, Celexa and Lexapro, a class action claims in Federal Court. Named plaintiffs ...

The U.S. Department of Justice has filed a complaint against Forest Laboratories, the maker of antidepressants Celexa and Lexapro, accusing it of being underhanded in how it disclosed its research.

Forest Pharmaceuticals will pay $313 million and plead guilty to federal charges related to distribution of an unapproved drug to treat hypothyroidism, the illegal promotion an anti-depressant drug ...